VistaGen Therapeutics, Inc. (VTGN)
NASDAQ·Healthcare·Biotechnology
$0.17
+3.03%
Mkt Cap $7.43M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$0.95
Range $0.90 – $1.00
Implied Upside
+458.0%
Consensus $0.95 vs current $0.17
NASDAQ·Healthcare·Biotechnology
$0.17
+3.03%
Mkt Cap $7.43M
No recent rating data.
Price Target (4 analysts)
$0.95
Range $0.90 – $1.00
+458.0%
Consensus $0.95 vs current $0.17